Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New Taisho drug has promising pharmacological profile

March 7, 2012

Icatibant acetate may improve acquired angioedema

March 7, 2012

Canadian study reveals new potential tool for prostate cancer diagnosis

March 6, 2012

Phase II AMG-853 trial does not meet primary endpoint

March 6, 2012

German study reveals new prognostic marker for penile cancer

March 5, 2012

New calcium-activated potassium channel blocker shows potential in IBD model

March 2, 2012

New marker and potential therapeutic target identified for castration-resistant prostate cancer

March 1, 2012

Potassium channel blocker has antiobesity effects in animal models

March 1, 2012

Researchers identify biomarker for ulcer-type interstitial cystitis

March 1, 2012

Phase II trial assesses safety paclitaxel/everolimus combination in advanced urothelial cancer

Feb. 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...